Your browser doesn't support javascript.
loading
Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus.
August, Allison; Attarwala, Husain Z; Himansu, Sunny; Kalidindi, Shiva; Lu, Sophia; Pajon, Rolando; Han, Shu; Lecerf, Jean-Michel; Tomassini, Joanne E; Hard, Marjie; Ptaszek, Leon M; Crowe, James E; Zaks, Tal.
Affiliation
  • August A; Moderna, Inc., Cambridge, MA, USA. Allison.august@modernatx.com.
  • Attarwala HZ; Moderna, Inc., Cambridge, MA, USA.
  • Himansu S; Moderna, Inc., Cambridge, MA, USA.
  • Kalidindi S; Moderna, Inc., Cambridge, MA, USA.
  • Lu S; Moderna, Inc., Cambridge, MA, USA.
  • Pajon R; Moderna, Inc., Cambridge, MA, USA.
  • Han S; Moderna, Inc., Cambridge, MA, USA.
  • Lecerf JM; Moderna, Inc., Cambridge, MA, USA.
  • Tomassini JE; Moderna, Inc., Cambridge, MA, USA.
  • Hard M; Moderna, Inc., Cambridge, MA, USA.
  • Ptaszek LM; Massachusetts General Hospital, Boston, MA, USA.
  • Crowe JE; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Zaks T; Moderna, Inc., Cambridge, MA, USA.
Nat Med ; 28(5): 1095-1096, 2022 May.
Article in En | MEDLINE | ID: mdl-35449420
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Type: Article Affiliation country: United States